Get the Stockscreener App
4.48
23.55%
-1.38
Veraxa Biotech Ag stock is traded at $4.48, with a volume of 749.21K.
It is down -23.55% in the last 24 hours and up +0.00% over the past month.
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.
See More
Previous Close:
$5.86
Open:
$5.3
24h Volume:
749.21K
Relative Volume:
22.16
Market Cap:
$633.51M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$4.20
$5.30
1-Week Range:
$4.20
$26.01
52-Week Range:
$4.20
$26.01
Veraxa Biotech Ag Stock (VRXA) Company Profile
Compare VRXA vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VRXA
Veraxa Biotech Ag
|
4.48 | 633.51M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Veraxa Biotech Ag Stock (VRXA) Latest News
VERAXA Biotech (NASDAQ: VRXA) Reports Proof-of-Concept Data for BiTAC-ADC Cancer Therapy Platform - USA Today
VERAXA Biotech Reports Proof-of-Concept Data for Tumor-Restricted BiTAC-ADC Cancer Therapy Platform - citybuzz -
Veraxa Biotech reports data on BiTAC-ADC cancer platform By Investing.com - Investing.com Australia
Veraxa Biotech reports data on BiTAC-ADC cancer platform - Investing.com
VERAXA’s cancer therapy platform clears lab test, seeks partners - Stock Titan
VERAXA Biotech AG: Advancing Next-Generation Antibody-Based Cancer Therapies - citybuzz -
Why VERAXA Biotech AG (VRXA) Is 'One to Watch' - Yahoo Finance
Veraxa Biotech: Post-Merger Valuation Does Not Match The Risk - Seeking Alpha
VERAXA Biotech AG’s Diversified Oncology Pipeline Positions It as a Company to Watch - citybuzz -
VRXA - Finviz
Veraxa Biotech Holding (VRXAW) Stock Analysis Report | Financials & Insights - Benzinga
Number of employees of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Veraxa Biotech AG Financial Statements – NASDAQ:VRXAW - TradingView
Current ratio of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
Return on invested capital % of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Price to sales ratio of Veraxa Biotech AG – BOATS:VRXAW - TradingView
Enterprise value to EBITDA ratio of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Net margin % of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
EBITDA of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
VRXA Price Today: Veraxa Biotech AG Stock Price, Quote & Chart | MEXC - MEXC
Operating expenses (excl. COGS) of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Total common shares outstanding of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Price to sales ratio of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Gross margin % of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Total liabilities of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Cost of goods sold of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Total equity of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Net income of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Enterprise value of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Free float of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Inventory turnover of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Total liabilities of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
Cash from financing activities of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Free cash flow of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Debt to assets ratio of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
EBITDA margin % of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Veraxa Biotech AG Cash Flow – NASDAQ:VRXAW - TradingView
EBIT of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Equity in earnings of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Free cash flow per share of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Enterprise value to EBITDA ratio of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
Operating margin % of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Revenue per share of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Quick ratio of Veraxa Biotech AG – NASDAQ:VRXA - TradingView
CapEx per share of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Operating cash flow per share of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Number of shareholders of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Price to book ratio of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
EBITDA per share of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Total assets of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Quick ratio of Veraxa Biotech AG – NASDAQ:VRXAW - TradingView
Veraxa Biotech Ag Stock (VRXA) Financials Data
There is no financial data for Veraxa Biotech Ag (VRXA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.74%
1.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):